Elite Pharmaceuticals, Inc. (traded on the OTC markets under the ticker symbol ELTP) trades at approximately $0.28 per share. Share values for small-cap specialty pharmaceutical developers fluctuate throughout active trading sessions based on daily liquidity, regulatory updates regarding generic and proprietary drug applications, and periodic financial earnings disclosures monitored by micro-cap investors and specialized healthcare equity traders.